Portal de Periódicos da CAPES

Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data

2020; Elsevier BV; Volume: 33; Linguagem: Inglês

10.1016/j.dib.2020.106519

2352-3409

Michaël Hardy, Isabelle Michaux, Sarah Lessire, Jonathan Douxfils, Jean‐Michel Dogné, Marion Bareille, Geoffrey Horlait, Pierre Bulpa, Céline Chapelle, Silvy Laporte, Sophie Testa, Hugues Jacqmin, Thomas Lecompte, Alain Dive, François Mullier,

Atrial Fibrillation Management and Outcomes

This data article accompanies the manuscript entitled: "Prothrombotic Disturbances of hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Cohort Study" submitted to Thrombosis Research by the same authors. We report temporal changes of plasma levels of an extended set of laboratory parameters during the ICU stay of the 21 COVID-19 patients included in the monocentre cohort: CRP, platelet count, prothrombin time; Clauss fibrinogen and clotting factors II, V and VIII levels, D-dimers, antithrombin activity, protein C, free protein S, total and free tissue factor pathway inhibitor, PAI-1 levels, von Willebrand factor antigen and activity, ADAMTS-13 (plasma levels); and of two integrative tests of coagulation (thrombin generation with ST Genesia) and fibrinolysis (global fibrinolytic capacity - GFC). Regarding hemostasis, we used double-centrifuged frozen citrated plasma prospectively collected after daily performance of usual coagulation tests. Demographic and clinical characteristics of patients and thrombotic and hemorrhagic complications were also collected from patient's electronic medical reports.